Covered recipient · General Payments record
MELINDA B MICHALSKI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,922.54
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,033.33 | 50 |
| Education | $169.94 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $169.94 | 2 |
| Merck Sharp & Dohme Corporation | $126.94 | 7 |
| Lilly USA, LLC | $102.38 | 4 |
| Daiichi Sankyo Inc. | $76.03 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.75 | 3 |
| Genentech USA, Inc. | $63.35 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.01 | 2 |
| EISAI INC. | $51.45 | 3 |
| PharmaEssentia USA Corporation | $40.32 | 2 |
| Genmab U.S., Inc. | $39.85 | 2 |
| Coherus Biosciences Inc. | $37.10 | 1 |
| PFIZER INC. | $33.21 | 2 |
| E.R. Squibb & Sons, L.L.C. | $30.94 | 1 |
| Incyte Corporation | $30.75 | 2 |
| Stemline Therapeutics Inc. | $30.45 | 2 |
| Ipsen Biopharmaceuticals, Inc | $26.76 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.25 | 1 |
| TerSera Therapeutics LLC | $20.24 | 1 |
| GlaxoSmithKline, LLC. | $19.80 | 1 |
| ABBVIE INC. | $18.56 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.55 | 1 |
| GENZYME CORPORATION | $18.26 | 1 |
| Agios Pharmaceuticals, Inc. | $18.00 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.77 | 1 |
| Janssen Pharmaceuticals, Inc | $17.47 | 1 |
| Janssen Biotech, Inc. | $16.67 | 1 |
| ARRAY BIOPHARMA INC | $16.35 | 1 |
| SOBI, INC | $15.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.